These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 23212203

  • 1. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A.
    Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
    [Abstract] [Full Text] [Related]

  • 2. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
    Bacsal K, Wen DS, Chee SP.
    Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of angiography in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A, Cheung CM.
    Am J Ophthalmol; 2010 Dec; 150(6):888-93. PubMed ID: 20933219
    [Abstract] [Full Text] [Related]

  • 4. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM.
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [Abstract] [Full Text] [Related]

  • 5. Vogt-Koyanagi-Harada Disease Managed With Immunomodulatory Therapy Within 3 Months of Disease Onset.
    Ei Ei Lin Oo, Chee SP, Wong KKY, Hla Myint Htoon.
    Am J Ophthalmol; 2020 Dec; 220():37-44. PubMed ID: 32738228
    [Abstract] [Full Text] [Related]

  • 6. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA, Gupta V, Hemachandran S, Herbort CP, Abu El-Asrar AM.
    Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
    [Abstract] [Full Text] [Related]

  • 7. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP, Mantovani A, Bouchenaki N.
    Int Ophthalmol; 2007 Sep; 27(2-3):173-82. PubMed ID: 17457515
    [Abstract] [Full Text] [Related]

  • 8. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.
    Knecht PB, Mantovani A, Herbort CP.
    Int Ophthalmol; 2013 Oct; 33(5):571-7. PubMed ID: 23277207
    [Abstract] [Full Text] [Related]

  • 9. Choroidal folds in acute Vogt-Koyanagi-Harada disease.
    Zhao C, Zhang M, Wen X, Dong F, Han B, Du H.
    Ocul Immunol Inflamm; 2009 Oct; 17(4):282-8. PubMed ID: 19657984
    [Abstract] [Full Text] [Related]

  • 10. Choroidal folds in Vogt-Koyanagi-Harada disease.
    Wu W, Wen F, Huang S, Luo G, Wu D.
    Am J Ophthalmol; 2007 May; 143(5):900-901. PubMed ID: 17452188
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt-Koyanagi-Harada disease.
    Tobaigy MF, Abouammoh MA, AlBloushi AF, Saifaldein AA, Gikandi P, Almousa AN, Herbort CP, El-Asrar AA.
    Acta Ophthalmol; 2024 Aug; 102(5):e679-e686. PubMed ID: 38131519
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A.
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [Abstract] [Full Text] [Related]

  • 13. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.
    da Silva FT, Hirata CE, Sakata VM, Olivalves E, Preti R, Pimentel SL, Gomes A, Takahashi WY, Costa RA, Yamamoto JH.
    BMC Ophthalmol; 2012 Aug 13; 12():40. PubMed ID: 22889440
    [Abstract] [Full Text] [Related]

  • 14. Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography.
    Altan-Yaycioglu R, Akova YA, Akca S, Yilmaz G.
    Ocul Immunol Inflamm; 2006 Jun 13; 14(3):171-9. PubMed ID: 16766401
    [Abstract] [Full Text] [Related]

  • 15. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, AlBloushi AF, Gikandi PW, Hardarson SH, Stefánsson E.
    Br J Ophthalmol; 2019 Dec 13; 103(12):1695-1699. PubMed ID: 30798260
    [Abstract] [Full Text] [Related]

  • 16. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D.
    Eye (Lond); 2008 Sep 13; 22(9):1124-31. PubMed ID: 17479116
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
    Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D.
    Acta Ophthalmol; 2013 Sep 13; 91(6):e486-93. PubMed ID: 23575246
    [Abstract] [Full Text] [Related]

  • 18. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N, Morisod L, Herbort CP.
    Klin Monbl Augenheilkd; 2000 May 13; 216(5):290-4. PubMed ID: 10863695
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
    Chee SP, Jap A, Bacsal K.
    Am J Ophthalmol; 2009 Jan 13; 147(1):154-161.e1. PubMed ID: 18834575
    [Abstract] [Full Text] [Related]

  • 20. [Fundus fluorescein and indocyanine green angiographic study of Behcet's disease and Vogt-Koyanagi-Harada syndrome].
    Chen L, Yang P, Wen F, Zhou H, Huang X.
    Zhonghua Yan Ke Za Zhi; 2002 Apr 13; 38(4):210-2. PubMed ID: 12133388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.